An attending cardiologist is the lead inventor of a novel transcatheter pacing system and holds a patent that was recently licensed to a major medical device manufacturer. The manufacturer pays the cardiologist royalties based on commercial sales. The cardiologist is evaluating a 75-year-old patient with symptomatic sick sinus syndrome who requires permanent pacemaker implantation. The cardiologist believes the novel pacing system is clinically superior for this specific patient. Concurrently, the cardiologist serves as a voting member of the hospital's Value Analysis Committee, which is meeting next week to determine whether to authorize a bulk purchase contract for this new device. Which of the following best outlines the physician's ethical and professional obligations in this scenario?
- Disclose the financial conflict to the patient prior to obtaining informed consent for the procedure, disclose the conflict to the Value Analysis Committee, and recuse themselves from the committee's vote regarding the device.Answer
- BRecuse themselves from the Value Analysis Committee vote to satisfy institutional rules, but proceed with the implant without disclosing the royalty agreement to the patient, as the device is objectively the standard of care.
- CDisclose the financial interest to the state medical board to fulfill mandatory reporting requirements, but withhold the conflict from the patient to prevent undermining trust in the therapeutic relationship.
- DTransfer the patient's care to another electrophysiologist in the practice to perform the procedure, deliberately omitting the royalty information during the patient handoff to prevent provider bias against the device.
- EInform the patient of the financial interest, but require the patient to undergo a formal legal competence evaluation by a judge before they can validly consent to receiving the physician's proprietary device.